Infections in Oxfordshire Research Database (IORD) 2021
Administrative data:
Exam - Inpatient
Blood tests
Dataset Records for Blood tests
Displaying 51 - 100 of 1806
Prevalence of chronic kidney disease in Kazakhstan: evidence from a national cross-sectional study
GHDx Entry last modified on: Dec 12, 2023
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Colombia Vital Statistics - Births 2021
Estadísticas Vitales - EEVV - 2021; Nacimientos 2021
Vital registration:
Subnationally representative - Urban-rural representative
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada. Preprint.
GHDx Entry last modified on: Nov 5, 2021
South Korea National Health and Nutrition Examination Survey 2021
KNHANES VIII (2021)
Survey:
Cross-sectional - Exam - Individual - Nationally representative
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
Viet Nam STEPS Noncommunicable Disease Risk Factors Survey 2021
Survey:
Nationally representative
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Peru Demographic and Family Health Survey 2021
Encuesta Demográfica y de Salud Familiar (ENDES) 2021
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Armenia Integrated Living Conditions Survey 2021
Survey:
Household - Interview - Urban-rural representative
Niger STEPS Noncommunicable Disease Risk Factors Survey 2021
Mesure des Facteurs de Risque des Maladies Non Transmissibles au Niger
Survey:
Household
India - Chennai CHILDS Trust Medical Research Foundation (CTMRF) Hospital Inpatient Data 2021
Administrative data:
Inpatient
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey
Survey:
Epi surveillance
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
Senegal Malaria Indicator Survey 2020-2021
Enquête des Indicateurs du Paludisme au Sénégal 2020-2021 (EIPS 2020-2021)
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021
COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021)
Epi surveillance:
Cross-sectional - Individual
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
33.98% of Tripura has COVID-19 antibody in them, shows sero survey
Survey:
Epi surveillance
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Kenya Malaria Indicator Survey 2020
Survey:
Cross-sectional - GPS coordinates (GIS) - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
India - Haryana Covid-19 Sero Survey Round 2, October 2020
Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round)
Survey:
Cross-sectional - Epi surveillance - Urban-rural representative
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2020, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II
Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase
Survey:
Individual - Interview
Kolkata: One in Four People Have Covid Antibodies
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey
Survey:
Cross-sectional - Epi surveillance - Individual
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint
GHDx Entry last modified on: Mar 14, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
[Preliminary results of the National Health and Nutrition Survey COVID-19]
Communiqué 255: Resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19
Survey:
Cross-sectional - Epi surveillance - Household - Individual - Nationally representative
Mexico National Health and Nutrition Survey (ENSANUT) about COVID-19 2020
Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19, ENSANUT Continua COVID-19
Epi surveillance:
Household - Interview - Urban-rural representative
United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020
HAARVI
Survey:
Health facility - Longitudinal - Outpatient
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Scientific literature:
Epi surveillance
India - Haryana Covid -19 Sero Survey Round 1, August 2020
Sero-prevalence of anti-SARS-CoV-2 IgG antibodies in Haryana, India: a Population-Based Cross Sectional Study
Survey:
Epi surveillance
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares -
Canada COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Subscribe